Annual EBIT
-$210.96 M
-$28.24 M-15.45%
December 31, 2023
Summary
- As of February 10, 2025, DCPH annual earnings before interest & taxes is -$210.96 million, with the most recent change of -$28.24 million (-15.45%) on December 31, 2023.
- During the last 3 years, DCPH annual EBIT has risen by +$60.23 million (+22.21%).
Performance
DCPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$48.85 M
+$2.39 M+4.67%
March 1, 2024
Summary
- As of February 10, 2025, DCPH quarterly earnings before interest & taxes is -$48.85 million, with the most recent change of +$2.39 million (+4.67%) on March 1, 2024.
- Over the past year, DCPH quarterly EBIT has increased by +$4.84 million (+9.02%).
Performance
DCPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$206.55 M
+$4.41 M+2.09%
March 1, 2024
Summary
- As of February 10, 2025, DCPH TTM earnings before interest & taxes is -$206.55 million, with the most recent change of +$4.41 million (+2.09%) on March 1, 2024.
- Over the past year, DCPH TTM EBIT has increased by +$333.00 thousand (+0.16%).
Performance
DCPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DCPH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.4% | +9.0% | +0.2% |
| 3 y3 years | +22.2% | +9.0% | +0.2% |
| 5 y5 years | -111.4% | +9.0% | +0.2% |
DCPH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +15.5% | +42.2% | +11.6% | +81.0% | +13.0% | +45.3% |
| 5 y | 5-year | +15.5% | +42.2% | +11.6% | +81.0% | +13.0% | +45.3% |
| alltime | all time | +1098.1% | +42.2% | +704.3% | +81.0% | +3301.1% | +45.3% |
Deciphera Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$48.85 M(-4.7%) | -$206.55 M(-2.1%) |
| Dec 2023 | -$210.96 M(+15.5%) | -$51.24 M(-4.6%) | -$210.96 M(+2.0%) |
| Sep 2023 | - | -$53.69 M(+1.7%) | -$206.88 M(+4.4%) |
| Jun 2023 | - | -$52.77 M(-0.9%) | -$198.07 M(+4.8%) |
| Mar 2023 | - | -$53.26 M(+12.9%) | -$189.09 M(+3.5%) |
| Dec 2022 | -$182.72 M(-39.1%) | -$47.16 M(+5.1%) | -$182.72 M(-18.4%) |
| Sep 2022 | - | -$44.88 M(+2.5%) | -$223.96 M(-13.4%) |
| Jun 2022 | - | -$43.79 M(-6.6%) | -$258.75 M(-9.4%) |
| Mar 2022 | - | -$46.89 M(-47.0%) | -$285.48 M(-4.9%) |
| Dec 2021 | -$300.08 M(+10.7%) | -$88.40 M(+11.0%) | -$300.08 M(+9.2%) |
| Sep 2021 | - | -$79.67 M(+13.0%) | -$274.68 M(+6.1%) |
| Jun 2021 | - | -$70.51 M(+14.7%) | -$259.00 M(+0.6%) |
| Mar 2021 | - | -$61.49 M(-2.4%) | -$257.42 M(-5.1%) |
| Dec 2020 | -$271.19 M | -$63.00 M(-1.6%) | -$271.19 M(-1.5%) |
| Sep 2020 | - | -$64.00 M(-7.2%) | -$275.39 M(+2.9%) |
| Jun 2020 | - | -$68.93 M(-8.4%) | -$267.58 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$75.26 M(+12.0%) | -$220.08 M(+14.5%) |
| Dec 2019 | -$192.19 M(+92.6%) | -$67.20 M(+19.6%) | -$192.19 M(+22.2%) |
| Sep 2019 | - | -$56.18 M(+162.1%) | -$157.26 M(+25.3%) |
| Jun 2019 | - | -$21.43 M(-54.8%) | -$125.50 M(-0.2%) |
| Mar 2019 | - | -$47.37 M(+46.8%) | -$125.73 M(+26.0%) |
| Dec 2018 | -$99.77 M(+98.8%) | -$32.28 M(+32.2%) | -$99.77 M(+14.2%) |
| Sep 2018 | - | -$24.41 M(+12.7%) | -$87.38 M(+16.5%) |
| Jun 2018 | - | -$21.67 M(+1.2%) | -$74.98 M(+17.3%) |
| Mar 2018 | - | -$21.41 M(+7.6%) | -$63.91 M(+27.3%) |
| Dec 2017 | -$50.19 M(+94.3%) | -$19.89 M(+65.5%) | -$50.19 M(+29.2%) |
| Sep 2017 | - | -$12.02 M(+13.3%) | -$38.83 M(+18.1%) |
| Jun 2017 | - | -$10.60 M(+38.0%) | -$32.89 M(+47.6%) |
| Mar 2017 | - | -$7.68 M(-9.9%) | -$22.29 M(+52.6%) |
| Dec 2016 | -$25.83 M(+46.7%) | -$8.53 M(+40.5%) | -$14.61 M(+140.5%) |
| Sep 2016 | - | -$6.07 M | -$6.07 M |
| Dec 2015 | -$17.61 M | - | - |
FAQ
- What is Deciphera Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual EBIT year-on-year change?
- What is Deciphera Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly EBIT year-on-year change?
- What is Deciphera Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals TTM EBIT year-on-year change?
What is Deciphera Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of DCPH is -$210.96 M
What is the all time high annual EBIT for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual earnings before interest & taxes is -$17.61 M
What is Deciphera Pharmaceuticals annual EBIT year-on-year change?
Over the past year, DCPH annual earnings before interest & taxes has changed by -$28.24 M (-15.45%)
What is Deciphera Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of DCPH is -$48.85 M
What is the all time high quarterly EBIT for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$6.07 M
What is Deciphera Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, DCPH quarterly earnings before interest & taxes has changed by +$4.84 M (+9.02%)
What is Deciphera Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of DCPH is -$206.55 M
What is the all time high TTM EBIT for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high TTM earnings before interest & taxes is -$6.07 M
What is Deciphera Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, DCPH TTM earnings before interest & taxes has changed by +$333.00 K (+0.16%)